Follow
Luciano Marraffini
Luciano Marraffini
Verified email at rockefeller.edu
Title
Cited by
Cited by
Year
Multiplex genome engineering using CRISPR/Cas systems
L Cong, FA Ran, D Cox, S Lin, R Barretto, N Habib, PD Hsu, X Wu, ...
Science 339 (6121), 819-823, 2013
152472013
DNA targeting specificity of RNA-guided Cas9 nucleases
PD Hsu, DA Scott, JA Weinstein, F Ran, S Konermann, V Agarwala, Y Li, ...
Nature biotechnology 31 (9), 827-832, 2013
46282013
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini
Nature biotechnology 31 (3), 233-239, 2013
25902013
CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA
LA Marraffini, EJ Sontheimer
science 322 (5909), 1843-1845, 2008
18842008
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea
LA Marraffini, EJ Sontheimer
Nature Reviews Genetics 11 (3), 181-190, 2010
11962010
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
D Bikard, W Jiang, P Samai, A Hochschild, F Zhang, LA Marraffini
Nucleic acids research 41 (15), 7429-7437, 2013
11382013
Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria
LA Marraffini, AC DeDent, O Schneewind
Microbiology and Molecular Biology Reviews 70 (1), 192-221, 2006
8552006
Self versus non-self discrimination during CRISPR RNA-directed immunity
LA Marraffini, EJ Sontheimer
Nature 463 (7280), 568-571, 2010
8442010
CRISPR-Cas systems: prokaryotes upgrade to adaptive immunity
R Barrangou, LA Marraffini
Molecular cell 54 (2), 234-244, 2014
7902014
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
D Bikard, CW Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146-1150, 2014
7602014
CRISPR-Cas immunity in prokaryotes
LA Marraffini
Nature 526 (7571), 55-61, 2015
7352015
Target DNA interference with crRNA
EJ Sontheimer, LA Marraffini
US Patent App. 12/565,589, 2010
4702010
Cas9 specifies functional viral targets during CRISPR–Cas adaptation
R Heler, P Samai, JW Modell, C Weiner, GW Goldberg, D Bikard, ...
Nature 519 (7542), 199-202, 2015
4482015
CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection
D Bikard, A Hatoum-Aslan, D Mucida, LA Marraffini
Cell host & microbe 12 (2), 177-186, 2012
4012012
Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity
P Samai, N Pyenson, W Jiang, GW Goldberg, A Hatoum-Aslan, ...
Cell 161 (5), 1164-1174, 2015
3982015
Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site
A Hatoum-Aslan, I Maniv, LA Marraffini
Proceedings of the National Academy of Sciences 108 (52), 21218-21222, 2011
3962011
Protein sorting to the cell wall envelope of Gram-positive bacteria
H Ton-That, LA Marraffini, O Schneewind
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1694 (1-3), 269-278, 2004
3302004
Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers
O Niewoehner, C Garcia-Doval, JT Rostøl, C Berk, F Schwede, L Bigler, ...
Nature 548 (7669), 543-548, 2017
3062017
Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting
GW Goldberg, W Jiang, D Bikard, LA Marraffini
Nature 514 (7524), 633-637, 2014
2642014
Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids
W Jiang, I Maniv, F Arain, Y Wang, BR Levin, LA Marraffini
PLoS genetics 9 (9), e1003844, 2013
2332013
The system can't perform the operation now. Try again later.
Articles 1–20